Immuron (IMRN) Other Non Operating Income (2017 - 2023)
Immuron (IMRN) posted quarterly Other Non Operating Income of $4441.0 for Q4 2023, up 629.95% year-on-year from $608.4 in Q4 2022, and up 629.95% on a QoQ basis from -$838.0 in Q4 2022.
Immuron (IMRN) Other Non Operating Income (2017 - 2023) Analysis & Trends
Immuron (IMRN) has reported Other Non Operating Income for 7 consecutive years, with $4441.0 the latest figure, recorded in Q4 2023.
- Quarterly Other Non Operating Income rose 629.95% year-over-year to $4441.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $3455.7 (up 382.37% YoY) and the FY2023 annual result came in at -$714.7, changed N/A from the prior year.
- Other Non Operating Income rose to $4441.0 in Q4 2023 per IMRN's latest filing, from -$838.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for IMRN reached as high as $4441.0 in Q4 2023 and fell as low as -$838.0 in Q4 2022.
- A 5-year average of $643.43 and a median of -$150.57 in 2020 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 25400.45% — and 2023, when it jumped 629.95%.
- Year by year, Other Non Operating Income stood at -$238.57 in 2019, then soared by 36.89% to -$150.57 in 2020, then jumped by 102.2% to $3.31 in 2021, then slumped by 25400.45% to -$838.0 in 2022, then soared by 629.95% to $4441.0 in 2023.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $4441.0, -$838.0, and $3.31 for Q4 2023, Q4 2022, and Q4 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4,441.00 |
| Dec 31, 2022 | -838.00 |
| Dec 31, 2021 | 3.31 |
| Dec 31, 2020 | -150.57 |
| Dec 31, 2019 | -238.57 |
| Dec 31, 2018 | -112,270.00 |
| Dec 31, 2017 | 28,281.00 |